Pregnancy category change for efavirenz.
D000014:Abnormalities, Drug-Induced / Q000175:diagnosis* / Q000453:epidemiology; D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D003616:Dandy-Walker Syndrome / Q000139:chemically induced / Q000175:diagnosis; D005260:Female; D005323:Fetal Monitoring / Q000379:methods; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D008591:Meningomyelocele / Q000139:chemically induced / Q000175:diagnosis; D008991:Monitoring, Physiologic / Q000379:methods; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology; D011261:Pregnancy Trimester, First; D012189:Retrospective Studies
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; C098320:efavirenz